Dascena, Inc., a healthcare technology company that develops machine learning algorithms to improve patient outcomes, announced today that Andrew Pucher has been appointed Chief Executive Officer, effective immediately. Pucher previously served as Dascena’s Chief Financial Officer, and succeeds the company’s founder, Ritankar Das. Das will remain a strategic advisor to the company and a Board director. Andrew was also named to the company’s Board of Directors.
“On behalf of the Board, I would like to congratulate Andrew on his promotion to CEO and welcome him to the Board of Directors. In his time as CFO, the Board has been impressed by Andrew’s leadership, strategic thinking, and execution. We are confident that Andrew will continue to leverage his deep financial and operating experience across healthcare to commercialize our solutions across multiple end markets,” said Steve Goldman, Chairman of the Board.
“I’m excited by the opportunity to lead Dascena as CEO,” said Pucher. “In our clinical studies and early partner deployments, we’ve proven that our machine learning technology solutions can improve patient outcomes. What excites me is the ability to deploy our solutions against new disease areas and other healthcare end markets. As an organization, I believe we have a great opportunity to deliver long-term value to patients, partners, and shareholders.”
Pucher joined Dascena from Tilray, Inc. where he served as Chief Corporate Development Officer through to the company’s successful sale for an implied valuation of $3.4 billion at closing. Previously, he was a Managing Director at Goldman Sachs, where he served as a senior leader within the investment bank’s Global Healthcare Group in New York City, as well as the Canadian Investment Banking franchise. Pucher holds a BBA from Simon Fraser University and JD/MBA from York University.
Dascena develops and implements clinically proven machine learning algorithms to improve patient outcomes. The company’s innovations help detect disease, improve the delivery of care, and save lives. Please visit us to learn more at dascena.com and on Twitter and LinkedIn.